Company Number: 14070101

Analysis Date: 2025-07-29 20:06 UTC

1. Credit Opinion: APPROVE with reservations.
   Hannah Emes CBT Ltd is a very small, micro-entity operating in the human health activities sector since 2022. The company shows modest but positive net current assets and shareholder funds, indicating a minimal buffer above liabilities. While the company is clearly in early stages and has no employees, it maintains up-to-date filings and no signs of financial distress or overdue obligations. Given its size and limited financial history, credit exposure should be modest and closely monitored, but current data suggest it can meet short-term liabilities.

2. Financial Strength:
   The balance sheet reveals total net assets of £534 as of April 2024, up slightly from £405 the previous year. All assets are current with no fixed assets reported, reflecting a very lean operation. The current assets of £15,969 against current liabilities of £15,435 yield a small net working capital of £534. The company has no long-term debt and fund structure is entirely equity-based, albeit minimal. Overall, financial strength is weak but stable, typical of a newly incorporated micro business with limited scale.

3. Cash Flow Assessment:
   Liquidity appears adequate to cover immediate obligations given current assets slightly exceed current liabilities. However, the company’s cash buffers are very thin (£15,969 current assets likely mostly cash or receivables) and working capital of £534 offers limited operational flexibility. The absence of employees and presumably low operating costs reduce cash burn risk. Going forward, cash flow will depend heavily on the company’s ability to generate revenue as it scales. Regular monitoring of cash inflows and outflows is advised.

4. Monitoring Points:

• Revenue growth and profitability trends as the company develops beyond inception stage.
• Changes in working capital, particularly current liabilities relative to current assets.
• Any new debt or credit facilities that might impact leverage and liquidity.
• Maintenance of timely filing and compliance with Companies House deadlines.
• Director’s continued involvement and any changes in ownership or control.
• Market conditions in the human health sector affecting demand for services.